Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study

Autor: Maxime Dougados, Philippe Goupille, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas, Adeline Ryussen-Witrand, Emilie Desfleurs, Audrey Lardy-Cleaud

Publikováno v: RMD Open, Vol 10, Iss 1 (2024)

Objective To compare the 1-year retention rate of secukinumab in axial spondyloarthritis (axSpA) and its predisposing factors with regard to its time of initiation (eg, right after or remotely from its launch).Methods Study design: Retrospective mult

Externí odkaz: https://doaj.org/article/a760ea7964cf438ca2dc3456a1053520

Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years

Autor: Bruno Fautrel, Laure Gossec, Pascal Richette, Daniel Wendling, Florian Lucasson, Krystel Aouad, Adeline Ryussen-Witrand

Publikováno v: RMD Open, Vol 8, Iss 1 (2022)

Externí odkaz: https://doaj.org/article/f5b73f82d25749a0af39f81c8cc37c66

Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years

Autor: Florian Lucasson, Pascal Richette, Krystel Aouad, Adeline Ryussen-Witrand, Daniel Wendling, Bruno Fautrel, Laure Gossec

Publikováno v: RMD Open : Rheumatic & Musculoskeletal Diseases
RMD Open : Rheumatic & Musculoskeletal Diseases, 2022, 8 (1), pp.e001986. ⟨10.1136/rmdopen-2021-001986⟩
RMD Open
RMD Open, Vol 8, Iss 1 (2022)

ObjectivesThe consequences of psoriasis associated to axial spondyloarthritis (axSpA) are unclear. The objectives were to determine the prevalence and the consequences of psoriasis in recent axSpA over 6 years of follow-up.MethodsThe multicentric pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ac2a2da9f024b548754bfdd89183435
https://doi.org/10.1136/rmdopen-2021-001986